Sector: MedicalInovio Biomedical Corporation (AMEX: INO)
Ranking History
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 14 |
Technical : | 286 |
Performance : | 59 |
Overall: | 88 |
Number of Stocks: | 306 |
Scan Date: | 10/20/2009 |
Sector: | Medical |
Funamental : | 14 |
Technical : | 232 |
Performance : | 4 |
Overall: | 23 |
Number of Stocks: | 305 |
Scan Date: | 10/15/2009 |
Sector: | Medical |
Funamental : | 14 |
Technical : | 215 |
Performance : | 5 |
Overall: | 20 |
Number of Stocks: | 305 |
Headlines
- Stocks on the Move: TPIV, INO, MBCI, CRXL
Nov 05, 2009 08:19 AM | CRXL, INO
- Inovio Biomedical Board of Directors Adds Two New Members
Oct 26, 2009 03:00 AM | INO, SNY, WMB
- Trading Review for Inovio Biomedical Corp. Issued by InvestorSoup.com
Oct 21, 2009 06:51 AM | BIIB, GENZ, GILD, INO
- Inovio Biomedical to Present at Investor Conferences
Oct 21, 2009 06:00 AM | INO
- Inovio Biomedical and Its Collaborators Present Research and Clinical Data at AIDS Vaccine 2009 Conference
Oct 20, 2009 06:00 AM | INO, MRK
- Inovio Biomedical Announces Initiation of HIV Clinical Trial for DNA Vaccine Delivered Using Electroporation
Oct 15, 2009 10:00 AM | INO
- Weekly Digest's Investor Essentials Special Report Identifies Unique Investing Opportunities in the H1N1 'Swine Flu' Outbreak
Oct 15, 2009 09:38 AM | AZN, GNBT, INO, NVAX
- Inovio Biomedical CEO Introduces DNA Vaccine Potential at 2009 World Knowledge Forum
Oct 13, 2009 09:01 AM | INO
- Small-Cap Biotech Stocks To Keep An Eye On
Oct 05, 2009 09:37 AM | AVII, CVM, HGSI, INO, ONCY
- Inovio Biomedical Demonstrates Protective Immune Responses Against Novel H1N1 (2009) Influenza Virus in Ferret Model
Oct 05, 2009 05:30 AM | INO
- Inovio Biomedical and NIH Vaccine Research Center Sign Research Collaboration Agreement to Develop Universal Influenza Vaccines
Aug 10, 2009 03:01 AM | INO
- First Human Demonstration of Significant, Persistent Antibody Response Using Electroporation-Delivered DNA Vaccine Published in Human Gene Therapy
Aug 05, 2009 03:01 AM | INO
- Inovio Closes $30 Million Registered Direct Offering
Jul 31, 2009 01:05 PM | INO
- Inovio Announces $30 Million Registered Direct Offering
Jul 30, 2009 07:47 AM | INO, RODM
- Inovio Biomedical Universal Influenza Vaccines Demonstrate 100% Protection Against Current Pandemic A/H1N1 Influenza Viruses in Animal Studies
Jul 29, 2009 06:04 AM | INO
- Inovio Biomedical Universal Dengue DNA Vaccine Demonstrates Strong Immune Responses Against All Four Serotypes
Jul 27, 2009 06:03 AM | INO
- Inovio Biomedical to Present at Jesup & Lamont Growth Stock Conference
Jul 27, 2009 06:01 AM | INO
- Inovio Biomedical H1N1 Influenza DNA Vaccines Demonstrate 100% Responses Against Swine Flu in Vaccinated Pigs
Jul 13, 2009 01:01 AM | INO
- Inovio Biomedical to Present at International DNA Vaccine Conference
Jul 06, 2009 03:01 AM | INO
- Inovio Biomedical, National Microbiology Laboratory, and University of Pennsylvania to Evaluate Candidate DNA Vaccines against “Swine” Influenza A (H1N1)
Jun 30, 2009 03:01 AM | INO
- Form 4 Williams David J For: Oct 26 (10K)
Oct 29, 2009 08:31 PM
- Form 3 Williams David J For: Oct 26 (10K)
Oct 29, 2009 08:30 PM
- Form 4 COLLINS MORTON For: Sep 30 (10K)
Oct 02, 2009 07:47 PM
- Form 4 NG TEE KHIANG For: Sep 30 (10K)
Oct 02, 2009 07:47 PM
- Form 4 BENITO SIMON X For: Sep 30 (10K)
Oct 02, 2009 07:47 PM
- Form 4 Rassas Kevin For: Sep 30 (10K)
Oct 02, 2009 07:47 PM
- Form 4 Sardesai Niranjan For: Sep 30 (10K)
Oct 02, 2009 07:47 PM
- Form 4 Kim Jong Joseph For: Sep 30 (10K)
Oct 02, 2009 07:46 PM
- Form 4 KIES PETER For: Sep 30 (10K)
Oct 02, 2009 07:46 PM
- Form 4 Fons Michael For: Sep 30 (10K)
Oct 02, 2009 07:45 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
INO
|
Compare to S&P
|
| YTD |
100.00 %
|
74.34 %
|
| 4 Weeks |
-38.46 %
|
-39.11 %
|
| 12 Weeks |
-52.07 %
|
-53.26 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 25.00 %
|
|
EPS Growth in Last Year: 33.33 %
|
|
Sales Growth in Last Quarter: 575.34 %
|
|
Sales Growth in Last Quarter: 275.87 %
|
|
